English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
Agilex Biolabs' Toxicology Tapped for SARS-CoV-2 Vaccine Research
May 17, 2021 21:00 HKT
President Xi Jinping reiterates the country's support for Traditional Chinese Medicine
May 13, 2021 22:04 HKT
Shineway (2877.HK) Q1 revenue increased by 37.0%
May 13, 2021 21:55 HKT
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
May 07, 2021 00:00 HKT
Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results
Apr 30, 2021 13:00 HKT
Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials
Apr 29, 2021 04:00 HKT
Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation
Apr 26, 2021 19:30 HKT
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields
Apr 26, 2021 10:33 HKT
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally
Apr 23, 2021 14:06 HKT
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect
Apr 22, 2021 12:00 HKT
Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia
Apr 19, 2021 09:00 HKT
Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business
Apr 08, 2021 10:00 HKT
Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans
Apr 07, 2021 15:00 HKT
Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021
Apr 06, 2021 13:29 HKT
China Medical System (0867.HK) Accelerating Development and Stepping to New Heights, Driven by Innovation
Apr 05, 2021 10:00 HKT
Universal Medical Announced its 2020 Annual Results
Mar 31, 2021 17:05 HKT
Azelis releases 'Action 2025', confirming sustainability as a key driver in growth strategy
Mar 31, 2021 11:00 HKT
Viva Biotech Announced 2020 Annual Results
Mar 31, 2021 07:05 HKT
China Medical System (0867) Ushers in a Revaluation with its Continuous Growth and Synergy between Innovative Business and New Businesses
Mar 30, 2021 20:35 HKT
TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020
Mar 24, 2021 07:35 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: